Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism.
Eguren-Santamaría I, Rodríguez I, Herrero-Martin C, Fernández de Piérola E, Azpilikueta A, Sánchez-Gregorio S, Bolaños E, Gomis G, Molero-Glez P, Chacón E, Mínguez JÁ, Chiva S, Diez-Caballero F, de Andrea C, Teijeira Á, Sanmamed MF, Melero I.
Eguren-Santamaría I, et al. Among authors: chiva s.
Oncoimmunology. 2024 Jul 9;13(1):2373519. doi: 10.1080/2162402X.2024.2373519. eCollection 2024.
Oncoimmunology. 2024.
PMID: 38988823
Free PMC article.